EASTBOURNE CAPITAL MANAGEMENT LLC/CA
CIK 1140888 · last filed 2010-05-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$431.50M
Companies
5
Total Filings
41
Lifetime Open-Market Net
-$212.14M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted | 10%+ Owner | 1,696,646 | — | — | -$6.02M | 13 | 2010-05-12 |
| Sarepta Therapeutics, Inc. (AVII) Delisted | 10%+ Owner | 943,202 | — | — | -$5.55M | 2 | 2010-03-08 |
| CASSAVA SCIENCES INC (PTIE) Delisted | 10%+ Owner | 3,265,627 | — | — | -$33.56M | 9 | 2009-09-29 |
| AMYLIN PHARMACEUTICALS INC (AMLN) Delisted | 10%+ Owner | 15,919,863 | — | — | -$95.50M | 15 | 2009-09-18 |
| MTG | 10%+ Owner | 14,900,000 | $28.96 | $431.50M | -$71.50M | 2 | 2009-09-16 |
Recent Filings · Page 2 of 5
41 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-07-15 | CASSAVA SCIENCES INC (PTIE) Delisted | Sell (S) | −90,778 | -$383.9K | EDGAR |
| 2009-07-09 | CASSAVA SCIENCES INC (PTIE) Delisted | Sell (S) | −368,000 | -$1.69M | EDGAR |
| 2009-06-15 | CASSAVA SCIENCES INC (PTIE) Delisted | Sell (S) | −285,703 | -$1.45M | EDGAR |
| 2009-06-10 | CASSAVA SCIENCES INC (PTIE) Delisted | Sell (S) | −461,274 | -$2.43M | EDGAR |
| 2009-04-06 | CASSAVA SCIENCES INC (PTIE) Delisted | Sell (S) | −900,000 | -$3.73M | EDGAR |
| 2009-03-13 | MTG | Buy (P) | +3,061,257 | $2.62M | EDGAR |
| 2009-03-04 | CASSAVA SCIENCES INC (PTIE) Delisted | Sell (S) | −1,000,000 | -$3.58M | EDGAR |
| 2009-02-17 | MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted | Buy (P) | +27,422 | $12.5K | EDGAR |
| 2009-02-12 | MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted | Buy (P) | +192,124 | $86.1K | EDGAR |
| 2009-02-03 | MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted | Buy (P) | +44,777 | $20.4K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.